The Heart Failure, LVAD & Heart Transplant Program at California Pacific Medical Center emphasizes total patient care and end-stage cardiac disease management. The goal of this approach is to provide patients with excellent results and the best opportunity for a successful outcome.

Our emphasis on total patient care and cardiac disease management creates a unique program with excellent outcomes and personal attention. Our team works with each patient to determine the most suitable treatment for your condition.

Program Highlights

California Pacific initiated the nation’s first heart transplant service in a private institution in 1984 and has been at the forefront of disease management and transplant ever since. We were the first center in the nation to successfully place and maintain a patient on a bi-ventricular assist device (BiVAD) while waiting for a donor heart and have been a leader in developing the “bridge-to-transplantation.”

With heart disease affecting an estimated 58 million people in the U.S. alone, medical researchers continue to pursue better treatment options. To this end, California Pacific is one of 20 clinical trial sites for the MicroMed DeBakey VAD®, a miniaturized heart pump for patients in end-stage heart failure. This device represents an exciting development in heart research, as its size and weight are believed to accommodate a broader patient population with minimally invasive implantation. California Pacific is also a HeartMate® center, offering this ventricular assist system as destination therapy, long-term treatment for patients who are ineligible for a heart transplant.